-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE 1-Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment

Reuters·12/04/2025 02:56:02

Please log in to view news